If you like what you read, subscribe to The Medical Letter to ensure your access to this unbiased source of drug information.
To read these articles you will need a free Adobe® Reader.
The Medical Letter on Drugs and Therapeutics
September 25, 2017 (Issue 1530)
- Drugs for Cognitive Loss and Dementia
- Tocilizumab (Actemra) for Giant Cell Arteritis
- Comparison Table: Drugs for Alzheimer’s Disease (online)
Canadian English Version: September 25, 2017 (Issue 1530)
- Drugs for Cognitive Loss and Dementia
- Tocilizumab (Actemra) for Giant Cell Arteritis
- Comparison Table: Drugs for Alzheimer’s Disease (online)
French Canadian Version: 23 octobre 2017 (ML 1530)
- Médicaments pour traiter les pertes cognitives et la démence
- Tocilizumab (Actemra) contre l’artérite à cellules géantes
- Tableau comparatif: Médicaments contre la maladie d’Alzheimer (en anglais – en ligne)
Subscribe for immediate online access